Home
About
Services
Partners
Client Portfolio
News
Contact
After tragedies and big losses, Hyundai looks to reverse North Korea fortunes
November 2, 2018
AbbVie lifts profit target after cancer drug powers quarterly beat
November 2, 2018
0
Humira biosimilars available at up to 80 percent discount in Europe: AbbVie
Published by
Muller&Green
at
November 2, 2018
Categories
RSS
Tags
AbbVie Inc said on Friday rival biosimilar versions of its best-selling drug Humira were available in Europe at discounts ranging from 10 percent to 80 percent.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more